Switch to
More onapp

How to use scorecard? Learn more

Concord Biotech Ltd

CONCORDBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,187 cr, stock is ranked 380
High RiskStock is 3.90x as volatile as Nifty
1,461.009.30 (+0.64%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,187 cr, stock is ranked 380
High RiskStock is 3.90x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
49.86
PB RatioPB Ratio
11.77
Dividend YieldDiv. Yield
Sector PESector PE
43.93
Sector PBSector PB
6.03
Sector Div YldSctr Div Yld
0.58%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Concord Biotech Limited, a biopharma company, engages in R&D, manufacturing, and marketing of pharmaceutical products in diverse therapeutic segments.

Investor PresentationView older 

Sep 6, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

2020202120222023543.85630.50736.35890.44169.10235.34174.94240.09
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Spurt in Volume 
Announced OnApr 12, 2024
Significant increase in volume has been observed in Concord Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Significant increase in volume has been observed in Concord Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Trading Window-XBRL 
Announced OnApr 1, 2024

CONCORD BIOTECH LIMITED has informed the Exchange about Closure of Trading Window | Download

CONCORD BIOTECH LIMITED has informed the Exchange about Closure of Trading Window | Download

Trading Window-XBRL 
Announced OnApr 1, 2024

CONCORD BIOTECH LIMITED has informed the Exchange about Closure of Trading Window | Download

CONCORD BIOTECH LIMITED has informed the Exchange about Closure of Trading Window | Download

See all events